Speaker Details

Jennifer Lin Hsiao, MD, FAAD

Jennifer Lin Hsiao, MD, FAAD

Keck School of Medicine, University of Southern California

SESSIONS

S034 Therapeutic Hotline
Mar 20, 2027 • 1:00 PM - 4:00 PM
S036 A New Paradigm in the Management of the Hidradenitis Suppurativa Disease Spectrum
Mar 21, 2027 • 1:00 PM - 4:00 PM
F055 Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach
Mar 21, 2027 • 3:30 PM - 5:30 PM
F088 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 22, 2027 • 3:30 PM - 5:30 PM

DISCLOSURES

AbbVie – Consultant(Fees), Speaker(Fees); Aclaris Therapeutics Inc. – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); Avalo – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Galderma – Speaker(Fees); Incyte – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Insmed – Consultant (1099 relationship)(Fees); Leo Pharma – Consultant (1099 relationship)(Fees); Merck – Consultant (1099 relationship)(Fees); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees), Speaker(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Speaker(Fees); Spyre Therapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Speaker(Fees);